| Jacob Edwin Kuperstock, MD | |
|
3801 University Dr Ste 300, Fairfax, VA 22030 | |
| (703) 383-8130 | |
| (703) 383-7355 |
| Full Name | Jacob Edwin Kuperstock |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 11 Years |
| Location | 3801 University Dr Ste 300, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700145182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 255486 (Massachusetts) | Secondary |
| 207YX0905X | Otolaryngology - Otolaryngology/facial Plastic Surgery | 0101266254 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Otolaryngology Associates Pc | 8022188069 | 24 |
News Archive
BioMers today announced the launch of two new aesthetic products for orthodontic treatment, the SimpliClear™ braces system and the ASTICS® Color retainers.
A molecular epigenetic marker is important for distinguishing patients with childhood leukemia at high and low risk of relapse even at the time of diagnosis.
TLC Vision Corporation (NASDAQ: TLCV) (TSX: TLC) announced today that, on September 16, 2009, it received letters from The Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the Company's common stock has not maintained a minimum value of publicly held shares of $15 million as required by Marketplace Rule 5450(b)(2)(C) or 5450(b)(3)(C) (the "MVPHS Rule") and the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Marketplace Rule 5450(a)(1) (the "Minimum Bid Price Rule").
The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases.
Scientists have identified a single genetic change in Salmonella that is playing a key role in the devastating epidemic of bloodstream infections currently killing around 400,000 people each year in sub-Saharan Africa.
› Verified 5 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
BioMers today announced the launch of two new aesthetic products for orthodontic treatment, the SimpliClear™ braces system and the ASTICS® Color retainers.
A molecular epigenetic marker is important for distinguishing patients with childhood leukemia at high and low risk of relapse even at the time of diagnosis.
TLC Vision Corporation (NASDAQ: TLCV) (TSX: TLC) announced today that, on September 16, 2009, it received letters from The Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the Company's common stock has not maintained a minimum value of publicly held shares of $15 million as required by Marketplace Rule 5450(b)(2)(C) or 5450(b)(3)(C) (the "MVPHS Rule") and the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Marketplace Rule 5450(a)(1) (the "Minimum Bid Price Rule").
The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases.
Scientists have identified a single genetic change in Salmonella that is playing a key role in the devastating epidemic of bloodstream infections currently killing around 400,000 people each year in sub-Saharan Africa.
› Verified 5 days ago
| Entity Name | Otolaryngology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861534836 PECOS PAC ID: 8022188069 Enrollment ID: O20080603000688 |
News Archive
BioMers today announced the launch of two new aesthetic products for orthodontic treatment, the SimpliClear™ braces system and the ASTICS® Color retainers.
A molecular epigenetic marker is important for distinguishing patients with childhood leukemia at high and low risk of relapse even at the time of diagnosis.
TLC Vision Corporation (NASDAQ: TLCV) (TSX: TLC) announced today that, on September 16, 2009, it received letters from The Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the Company's common stock has not maintained a minimum value of publicly held shares of $15 million as required by Marketplace Rule 5450(b)(2)(C) or 5450(b)(3)(C) (the "MVPHS Rule") and the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Marketplace Rule 5450(a)(1) (the "Minimum Bid Price Rule").
The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases.
Scientists have identified a single genetic change in Salmonella that is playing a key role in the devastating epidemic of bloodstream infections currently killing around 400,000 people each year in sub-Saharan Africa.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Edwin Kuperstock, MD 3801 University Dr Ste 300, Fairfax, VA 22030-2503 Ph: (703) 383-8130 | Jacob Edwin Kuperstock, MD 3801 University Dr Ste 300, Fairfax, VA 22030 Ph: (703) 383-8130 |
News Archive
BioMers today announced the launch of two new aesthetic products for orthodontic treatment, the SimpliClear™ braces system and the ASTICS® Color retainers.
A molecular epigenetic marker is important for distinguishing patients with childhood leukemia at high and low risk of relapse even at the time of diagnosis.
TLC Vision Corporation (NASDAQ: TLCV) (TSX: TLC) announced today that, on September 16, 2009, it received letters from The Nasdaq Stock Market indicating that, for the last 30 consecutive business days, the Company's common stock has not maintained a minimum value of publicly held shares of $15 million as required by Marketplace Rule 5450(b)(2)(C) or 5450(b)(3)(C) (the "MVPHS Rule") and the bid price of the Company's common stock has closed below the minimum $1.00 per share requirement for continued inclusion under Marketplace Rule 5450(a)(1) (the "Minimum Bid Price Rule").
The Cedars-Sinai Heart Institute has been awarded a $1.66 million, four-year grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to develop a measurement system that could help doctors predict which patients could be struck by sudden cardiac arrest, a heart rhythm disturbance that causes instant death in more than 95 percent of cases.
Scientists have identified a single genetic change in Salmonella that is playing a key role in the devastating epidemic of bloodstream infections currently killing around 400,000 people each year in sub-Saharan Africa.
› Verified 5 days ago
Dr. Mark I Rubinstein, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8316 Arlington Blvd, Suite 300, Fairfax, VA 22031 Phone: 703-573-7600 Fax: 703-560-3808 | |
Dr. Robert S Bahadori, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8316 Arlington Blvd, Suite 300, Fairfax, VA 22031 Phone: 703-573-7600 Fax: 703-560-3808 | |
Dr. Christopher W Tsang, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8280 Willow Oaks Corporate Dr Ste 300, Fairfax, VA 22031 Phone: 571-472-4300 | |
Gopesh Kumar Sharma, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8303 Arlington Blvd Ste 203, Fairfax, VA 22031 Phone: 703-573-3177 Fax: 703-573-3780 | |
Dr. Timothy Paul Mcbride, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 8316 Arlington Blvd, Suite 300, Fairfax, VA 22031 Phone: 703-573-7600 Fax: 703-560-3808 | |
Dr. Bryan Anthony Mckenzie, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 8316 Arlington Blvd, Suite 300, Fairfax, VA 22031 Phone: 703-573-7600 Fax: 703-560-3808 |